# Dose-finding Study of Moxidectin for Treatment of Scabies

> **NCT03905265** · PHASE2 · COMPLETED · sponsor: **Medicines Development for Global Health** · enrollment: 22 (actual)

## Conditions studied

- Scabies

## Interventions

- **DRUG:** Moxidectin Oral Product

## Key facts

- **NCT ID:** NCT03905265
- **Lead sponsor:** Medicines Development for Global Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-13
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03905265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03905265, "Dose-finding Study of Moxidectin for Treatment of Scabies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03905265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*